IVAX Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 10,100

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 5

IVAX General Information

Description

Manufacturer and developer of generic pharmaceuticals and veterinary products. The company's activities include research, development, manufacturing and marketing of generic pharmaceuticals and veterinary products, enabling customers to have quality products.

Contact Information

Website
www.ivax.com
Ownership Status
Acquired/Merged
Financing Status
Corporation
Corporate Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Acquirer
Teva Pharmaceutical Industries
Vertical(s)
Manufacturing
Corporate Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IVAX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IVAX‘s full profile, request access.

Request a free trial

IVAX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IVAX Investments & Acquisitions (5)

IVAX’s most recent deal was a Merger/Acquisition with Phoenix Scientific for . The deal was made on 11-May-2005.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Phoenix Scientific 11-May-2005 Merger/Acquisition Pharmaceuticals
Elan (Nasarel and Nasalide Product Lines, patents and trademarks) 01-Oct-2001 Corporate Asset Purchase Buildings and Property
Zenith Laboratories 29-Aug-1994 Merger/Acquisition Pharmaceuticals
McGaw Laboratories 05-Jan-1994 Merger/Acquisition Medical Supplies
Johnson Products 31-Aug-1993 Merger/Acquisition Personal Products
To view IVAX’s complete investments and acquisitions history, request access »

IVAX Exits (2)

IVAX’s most recent exit was on 05-Jan-1994 from McGaw Laboratories. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
McGaw Laboratories 05-Jan-1994 Completed
Johnson Products 31-Aug-1993 Merger/Acquisition Completed
To view IVAX’s complete exits history, request access »

IVAX FAQs

  • Where is IVAX headquartered?

    IVAX is headquartered in Miami, FL.

  • What is the size of IVAX?

    IVAX has 10,100 total employees.

  • What industry is IVAX in?

    IVAX’s primary industry is Pharmaceuticals.

  • Is IVAX a private or public company?

    IVAX is a Private company.

  • What is the current valuation of IVAX?

    The current valuation of IVAX is .

  • What is IVAX’s current revenue?

    The current revenue for IVAX is .

  • How much funding has IVAX raised over time?

    IVAX has raised $1.08B.

  • When was IVAX acquired?

    IVAX was acquired on 26-Jan-2006.

  • Who acquired IVAX?

    IVAX was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »